Motus GI Revenue and Competitors
Estimated Revenue & Valuation
- Motus GI's estimated annual revenue is currently $7.8M per year.
- Motus GI's estimated revenue per employee is $215,278
- Motus GI's total funding is $50M.
Employee Data
- Motus GI has 36 Employees.
- Motus GI grew their employee count by -28% last year.
Motus GI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer | Reveal Email/Phone |
2 | CEO and President | Reveal Email/Phone |
3 | VP, Research and Development | Reveal Email/Phone |
4 | VP, US Sales | Reveal Email/Phone |
5 | VP Sales and Commercial Operations | Reveal Email/Phone |
6 | Global Human Resources Director | Reveal Email/Phone |
7 | Senior Director Quality | Reveal Email/Phone |
8 | Director Engineering | Reveal Email/Phone |
9 | Clinical Research Associate | Reveal Email/Phone |
10 | Financial Controller | Reveal Email/Phone |
Motus GI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Motus GI?
Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The Pure-Vu® System is a 510(k) U.S. Food and Drug Administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. The Pure-Vu® System has received CE mark approval in Europe.
keywords:N/A
$50M
Total Funding
36
Number of Employees
$7.8M
Revenue (est)
-28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Motus GI News
Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients...
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve...
Motus GI Holdings, Inc. (NASDAQ:MOTS) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET. Company Participants.
Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy FORT LAUDERDALE, FL., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ('Motus GI' or the 'Company'), a medical technology company providing endoscopy solutions that improve clinical outcomes and ...
FORT LAUDERDALE, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management o ...
Other Companies in Miami
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6M | 36 | 16% | N/A |
#2 | $4.3M | 36 | 0% | N/A |
#3 | $7.1M | 36 | 9% | N/A |
#4 | $4.6M | 36 | -3% | N/A |
#5 | $4.3M | 36 | 6% | N/A |